SAN FRANCISCO /PRNewswire/—GI Partners announced today that it has completed the previously announced acquisition and merger of California Cryobank (CCB), the world's premier donor sperm and egg bank, and Cord Blood Registry (CBR), the world's largest stem cell collection and storage company. The combined company, which will operate under the California Cryobank Life Sciences name, is the leading player in the stem cell storage and reproductive tissue services markets.
The two best-in-class companies have joined to help nearly 700,000 families across more than 30 countries. The organization's full family-focused suite includes cord blood and cord tissue collection and storage, frozen donor sperm and frozen donor egg services, and fertility preservation storage services.
The combined company represents the fifth platform investment in GI Partners Fund V, a $2.8 billion private equity fund raised in 2017. Harris Williams served as financial advisor and Paul Hastings acted as legal advisor to GI Partners. Financing for the transaction was provided by Golub Capital and Owl Rock.
About California Cryobank Life Sciences
California Cryobank Life Sciences ("California Cryobank") is the clear market leader across the donor reproductive tissue and newborn stem cell collection and storage industries, offering a full family-focused suite of services. The company has helped nearly 700,000 families across more than 30 countries. The organization's best-in-class Life Sciences platform includes cord blood and cord tissue collection and storage, frozen donor sperm and frozen donor egg services, and fertility preservation storage services. Through its leading positions across these categories, the company continues to fulfill its mission of helping grow and protect families around the world.
